PL2696890T3 - Leczenie infekcji drobnoustrojowych - Google Patents

Leczenie infekcji drobnoustrojowych

Info

Publication number
PL2696890T3
PL2696890T3 PL12716348T PL12716348T PL2696890T3 PL 2696890 T3 PL2696890 T3 PL 2696890T3 PL 12716348 T PL12716348 T PL 12716348T PL 12716348 T PL12716348 T PL 12716348T PL 2696890 T3 PL2696890 T3 PL 2696890T3
Authority
PL
Poland
Prior art keywords
treatment
microbial infections
infections
microbial
Prior art date
Application number
PL12716348T
Other languages
English (en)
Inventor
Vincent O'Flaherty
Paul McCay
Original Assignee
National University Of Ireland, Galway
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National University Of Ireland, Galway filed Critical National University Of Ireland, Galway
Publication of PL2696890T3 publication Critical patent/PL2696890T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
PL12716348T 2011-04-15 2012-04-16 Leczenie infekcji drobnoustrojowych PL2696890T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11162678A EP2510944A1 (en) 2011-04-15 2011-04-15 Treatment of bacterial infections
EP12716348.3A EP2696890B1 (en) 2011-04-15 2012-04-16 Treatment of microbial infections
PCT/EP2012/056946 WO2012140272A1 (en) 2011-04-15 2012-04-16 Treatment of microbial infections

Publications (1)

Publication Number Publication Date
PL2696890T3 true PL2696890T3 (pl) 2021-12-27

Family

ID=44322681

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12716348T PL2696890T3 (pl) 2011-04-15 2012-04-16 Leczenie infekcji drobnoustrojowych

Country Status (9)

Country Link
US (2) US10828349B2 (pl)
EP (3) EP2510944A1 (pl)
JP (1) JP6510233B2 (pl)
CN (2) CN103648522A (pl)
AU (4) AU2012241705A1 (pl)
BR (1) BR112013026491B1 (pl)
CA (1) CA2833078A1 (pl)
PL (1) PL2696890T3 (pl)
WO (1) WO2012140272A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2720665A2 (en) 2011-06-15 2014-04-23 Rls Global Ab Detection and removal of carious dentin tissue.
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
EP2799068A1 (en) 2013-05-01 2014-11-05 National University of Ireland, Galway Antimicrobial compositions and methods for their production
US9872892B2 (en) 2013-05-08 2018-01-23 Novozymes A/S Animal feed enzymes
GB2535666B (en) 2014-04-30 2017-03-29 Matoke Holdings Ltd Antimicrobial compositions
EP2987408A1 (en) * 2014-08-20 2016-02-24 National University of Ireland, Galway Iodophor composition with improved stability in the presence of organic material
CN107708752A (zh) * 2015-02-03 2018-02-16 玛托克控股有限公司 抗微生物纤维和组合物
GB201518348D0 (en) * 2015-10-16 2015-12-02 Systagenix Wound Man Ip Co Bv Composition
US20180280340A1 (en) * 2017-03-30 2018-10-04 Konstantin Zubovskiy Method of treating and preventing infections
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
GB2589863A (en) * 2019-12-09 2021-06-16 Institute Of Tech Sligo Antimicrobial composition
WO2021229874A1 (ja) 2020-05-11 2021-11-18 株式会社日立ハイテク 自動分析装置および反応容器の挿入方法
GB2609445A (en) 2021-07-30 2023-02-08 Glasport Bio Ltd Compositions and methods
WO2024017883A1 (en) * 2022-07-18 2024-01-25 Acies Bio D.O.O. Peroxidase based biocontrol agents
EP4309500A1 (en) * 2022-07-18 2024-01-24 Acies Bio d.o.o. Peroxidase based biocontrol agents

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011312A (en) * 1975-06-25 1977-03-08 American Home Products Corporation Prolonged release drug form for the treatment of bovine mastitis
LU85479A1 (fr) 1984-07-25 1986-02-12 Oleofina Sa Compositions antibacteriennes de nourriture pour animaux et procede pour les preparer
US4726945A (en) 1986-06-17 1988-02-23 Colgate-Palmolive Co. Hair rinse conditioner
SE8702831L (sv) * 1987-07-10 1989-01-11 Ewos Ab Microbicid komposition
GB9002422D0 (en) * 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
US5888505A (en) * 1991-02-21 1999-03-30 Eoe, Inc. Method for selectively inhibiting the growth of microbes using a haloperoxidase-halide-peroxide system
NL9401048A (nl) * 1994-03-31 1995-11-01 Stichting Scheikundig Onderzoe Haloperoxidasen.
US5575993A (en) * 1994-08-31 1996-11-19 Buckman Laboratories International, Inc. Ionene polymers containing biologically-active anions
US5849291A (en) * 1994-10-17 1998-12-15 Symbollon Corporation Opthalmic non-irritating iodine medicament
CA2248065A1 (en) * 1996-03-06 1997-09-12 Novo Nordisk A/S A method of killing or inhibiting microbial cells
DE69714594T2 (de) * 1996-05-09 2003-04-24 Novozymes As Antimikrobielle peroxidase-zusammensetzungen
US6100080A (en) * 1996-12-18 2000-08-08 Novo Nordisk A/S Method for enzymatic treatment of biofilm
GB9708641D0 (en) 1997-04-29 1997-06-18 Knoll Ag Enzyme concentrate
BR9811156A (pt) * 1997-08-14 2000-07-25 Novo Nordisk As Composição enzimática antimicrobiana, uso da mesma, e, processos de inibição de microorganismos presentes em roupa suja, de conservação de um produto cosmético, e de limpeza, desinfecção ou inibição de crescimento microbiano em uma superfìcie dura
GB9814547D0 (en) * 1998-07-06 1998-09-02 Knoll Ag Sporicidal composition
CN1350428A (zh) * 1999-05-14 2002-05-22 奥它古大学 抗微生物性组合物
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
ATE390124T1 (de) * 2002-12-16 2008-04-15 Intervet Int Bv Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
ES2318747T3 (es) * 2005-06-13 2009-05-01 Flen Pharma N.V. Composiciones de peroxidasas antimicrobianas mejoradas.
US20060289354A1 (en) * 2005-06-15 2006-12-28 Buckman Laboratories International, Inc. Method and composition to control the growth of microorganisms in aqueous systems and on substrates
CA2636688C (en) * 2006-01-13 2014-09-09 Aseptix Research B.V. Enhanced activity biocidal hydrogen preoxide composition
NZ547859A (en) 2006-06-09 2009-05-31 Dec Int Nz Ltd Treatment method and composition for mastitis
EP1872791A1 (en) 2006-06-30 2008-01-02 Institut Pasteur Use of bacterial polysaccharides for biofilm inhibition
GB0619786D0 (en) 2006-10-06 2006-11-15 Inst Of Technology Sligo An antimicrobial and immunostimulatory system
AU2007307921B2 (en) * 2006-10-10 2013-03-28 Laclede, Inc. Methods and compositions for the treatment of vaginal diseases employing peroxide-producing enzymes and peroxidases
US20080299103A1 (en) * 2007-06-01 2008-12-04 Liliana George Well Preserved Aqueous Organic Compositions
AU2008275542B2 (en) * 2007-07-06 2014-06-05 Laclede, Inc. Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages
EP2217074A1 (en) * 2007-10-23 2010-08-18 Novozymes A/S Methods for killing spores and disinfecting or sterilizing devices
PL2276484T3 (pl) * 2008-03-26 2016-12-30 Mieszanina o działaniu przeciwdrobnoustrojowym
US8945540B2 (en) * 2008-05-09 2015-02-03 Exoxemis, Inc. Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
NZ600269A (en) * 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
WO2011074992A1 (en) 2009-12-15 2011-06-23 Dec International Nz Limited Treatment composition and method

Also Published As

Publication number Publication date
AU2012241705A1 (en) 2013-10-31
EP3888673A1 (en) 2021-10-06
BR112013026491B1 (pt) 2022-02-08
AU2021203874A1 (en) 2021-07-08
EP2696890A1 (en) 2014-02-19
BR112013026491A2 (pt) 2016-09-06
JP2014510777A (ja) 2014-05-01
NZ616550A (en) 2016-04-29
AU2019202045B2 (en) 2021-04-15
CN103648522A (zh) 2014-03-19
EP2696890B1 (en) 2021-03-03
AU2017202893A1 (en) 2017-05-18
JP6510233B2 (ja) 2019-05-08
US10828349B2 (en) 2020-11-10
EP2510944A1 (en) 2012-10-17
AU2019202045A1 (en) 2019-04-18
CN108704121A (zh) 2018-10-26
WO2012140272A1 (en) 2012-10-18
US20140134213A1 (en) 2014-05-15
CA2833078A1 (en) 2012-10-18
US20210106663A1 (en) 2021-04-15

Similar Documents

Publication Publication Date Title
PL2696890T3 (pl) Leczenie infekcji drobnoustrojowych
EP2723384A4 (en) TREATMENT OF PROTEINOPATHIES
EP2670434A4 (en) TREATMENT OF TAUOPATHIA
HK1205696A1 (en) Compositions for topical treatment of microbial infections
EP2717855A4 (en) PROCESSING METHODS
HK1210018A1 (en) Tailored liposomes for the treatment of bacterial infections
GB201217097D0 (en) Treatment of bacterial infection
HRP20160150T1 (en) Treatment of streptococcal infections
IL233486A (en) Synthetic peptides for the treatment of bacterial infections
HK1247572A1 (zh) 治療或預防細菌性陰道病的方法
ZA201308194B (en) Treatment of mastitis
ZA201308116B (en) Avian-based treatment for microbial infections
ZA201204249B (en) Treatment of microbial infections
PT2431030E (pt) Tratamento de infeções fúngicas
EP2665738A4 (en) COMPOUNDS FOR TREATING BACTERIAL INFECTION
EP2670407A4 (en) TREATMENT OF BACTERIAL INFECTIONS
GB201121044D0 (en) Treatment of solutions
EP2685820A4 (en) COMPOSITIONS AND METHODS FOR TREATING INFECTIONS
AU2011901619A0 (en) Avian-Based Treatment for Microbial Infection
GB201110602D0 (en) Methods of treatment
GB201109737D0 (en) Methods of treatment
GB201012168D0 (en) Treatment of viral infections
GB201001821D0 (en) Treatment of viral infections
AU2011901436A0 (en) Methods of treatment
AU2011902407A0 (en) Treatment of pain